Skip to main content
Annexon, Inc. logo

Annexon, Inc. — Investor Relations & Filings

Ticker · ANNX ISIN · US03589W1027 US Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2020-07-24 Regulatory Filings
Country US United States of America
Listing US ANNX

About Annexon, Inc.

https://annexonbio.com/

Annexon, Inc. is a clinical-stage biopharmaceutical company developing a new class of complement medicines. The company's therapeutic approach is centered on inhibiting C1q, the initiating molecule of the classical complement pathway. By blocking C1q at the start of this immune cascade, Annexon aims to prevent the inflammation and tissue damage that drive a range of diseases. Its pipeline is focused on developing treatments for classical complement-mediated disorders affecting the body, brain, and eye, which include autoimmune, neurodegenerative, and ophthalmic conditions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings
2020-07-24 English
S-1MEF
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering under the Securities Act of 1933. It includes details about the registration of additional shares, references to previous filings, and legal consents. This type of filing is related to capital raising activities and securities registration, not a financial report, earnings release, or management discussion. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive content related to the registration of securities.
2020-07-23 English
Director's Dealing 2020
Director's Dealing
2020-07-23 English
Regulatory Filings 2020
Regulatory Filings
2020-07-23 English
FORM 3 SUBMISSION
Director's Dealing
2020-07-23 English
FORM 3 SUBMISSION
Director's Dealing
2020-07-23 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.